This paradoxical loss of c-MYC has been observed in multiple myeloma, Hodgkin lymphoma, and in the c-MYC–addicted B-cell neoplasm Burkitt lymphoma, although its mechanistic explanation remained elusive (58–60). The gene discussed is MYC; the disease is plasma cell myeloma.